DUBLIN--(BUSINESS WIRE)--HiberGene Diagnostics, a company focused on the application of molecular technology to infectious disease testing, has completed CE marking of their HG SWIFT instrument.
This simple and easy to use instrument is designed exclusively for use with HiberGene’s growing portfolio of molecular tests for infectious diseases, including the recently launched HG Meningococcus, and the soon to be launched HG GBS, a rapid test for Group B Streptococcus.
This simple and easy to use instrument is designed exclusively for use with HiberGene’s growing portfolio of molecular tests for infectious diseases, including the recently launched HG Meningococcus, and the soon to be launched HG GBS, a rapid test for Group B Streptococcus.
